However, the Minneapolis Fed president says one move could still pave the way to a stronger economic recovery.
Read MoreFive of the market’s biggest names could be in a bubble. Here’s what you need to know now.
Read MoreStocks could head higher in the near term. Here’s why.
Read MoreThese 2 hot IPO stocks could be gearing up for more gains.
Read MoreAnalysts are bullish on these 5 stocks post-earnings.
Read MoreTrade Setup Buy Target: $22.94 Sell Target: $26.07 Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $8.00 or better Sell Price: TradersPro Sell Signal Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase III clinical trial for the treatment of angelman syndrome in adults; and completed […]
Read MorePlus, Novavax signed a deal with SK Bioscience to manufacture the antigen component of its COVID-19 vaccine candidate, Apple is reportedly preparing bundles of its digital services, and Tapestry shares are down after reporting earnings.
Read MoreThe market’s plunge from late February to March was perhaps the most rapid descent to bear market levels in history; the road back, while not as rapid, has also been remarkable, taking just about five months for the S&P 500 to follow the NASDAQ above its pre-pandemic highs, with the Dow Jones Industrial Average within […]
Read More